Former Sri Lankan president Mahinda Rajapaksa's son Namal denied entry into US; money laundering charges possible reason
A controversial Sri Lankan opposition legislator, on Thursday, said US authorities prevented him from taking a flight to Texas from Moscow where he was an observer for the Russian presidential election
Colombo: A controversial Sri Lankan opposition legislator, on Thursday, said US authorities prevented him from taking a flight to Texas from Moscow where he was an observer for the Russian presidential election.
Namal Rajapaksa, son of former strongman president Mahinda Rajapaksa, said the airline had been instructed not to allow him to board the flight to Houston.
Rajapaksa said on Twitter that he had been informed by Emirates Air "I won't make my Houston Flight as #US Officials instruct them to not let me board. Sure it has nothing to do with my name, being part of #lka opposition or my travel from #Russia."
The 31-year-old was invited by the Russian government to be a monitor of the presidential election won by Vladimir Putin.
US authorities do not comment on individual cases, but official sources said his name was likely on a travel watch list as a result of the money laundering charges he faces back home.
Namal Rajapaksa and a sibling have been charged with money-laundering. Other family members face corruption allegations.
Sri Lanka has announced it will set up special courts to investigate billions of dollars of corruption under former president Rajapaksa who was defeated in the 2015 elections.
His successor Maithripala Sirisena has said as many as half of all public procurement contracts under the Rajapaksa administration were corrupt.
Former president Rajapaksa is not under investigation and denies any wrongdoing.
Rhea Chakraborty had requested the ED to postpone the recording of her statement till the hearing of her plea in Supreme Court
The Gamaleya Institute developed the Russian vaccine using a human cell line first cultured in 1973 — the same line used in the Oxford-AstraZeneca vaccine.
Far from awe-inspiring Sputnik launch in 1957, Russia's COVID-19 vaccine met with concerns about science, safety
Sputnik V underscores how, like in the space race, competition to have the first vaccine is about international rivalries as much as science.